Trials / Completed
CompletedNCT04654390
The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
A Multi-center, Randomized, Double-Blind, Active-controlled, Phase3, Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 270 (actual)
- Sponsor
- Daewoong Pharmaceutical Co. LTD. · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the efficacy and safety of DWP16001 compared to active drug in the treatment of type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DWP16001 Amg | Tablets, Orally, Once daily |
Timeline
- Start date
- 2020-12-30
- Primary completion
- 2021-12-17
- Completion
- 2021-12-17
- First posted
- 2020-12-04
- Last updated
- 2022-04-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04654390. Inclusion in this directory is not an endorsement.